Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies

The Lancet ◽  
2016 ◽  
Vol 387 (10037) ◽  
pp. 2554-2564 ◽  
Author(s):  
Guillaume Lettre ◽  
Daniel E Bauer
2012 ◽  
Vol 2 (2) ◽  
pp. 57-60
Author(s):  
Jayanti Mishra ◽  
Sanghamitra Pati ◽  
Mohammad Akhtar Hussain ◽  
Niraj Srivastava ◽  
Sindhubala Mishra

The highest frequency of sickle cell gene in India is reported in Odisha. The present study was taken up to assess the presence of sickle cell disease among febrile patients of a medical college of eastern Odisha. Patients referred from both pediatric and medicine department to the Hematology section of the department of Pathology, SCB Medical College, Cuttack were subjected to measurement of RBC indices, Sickling test, Haemoglobin Electrophoresis and Fetal Haemoglobin Estimation. Out of total 1000 referred patients 76(7.6%) were found to be positive for sickling. Two‐third of sicklingpositive patients had sickle cell trait with electrophoretic AS band. There was a significant association between age and positive sickling (χ2 = 24.357; df = 4, P = <0.0001). No significant association was observed between sickling and gender. Sickle cell positive cases are not uncommon in eastern Odisha. Our study demonstrated sickle cell trait to be more common among screened patients than other forms of sickle cell diseases.


2018 ◽  
Vol 18 (2) ◽  
pp. 139-158 ◽  
Author(s):  
Marilyn J. Telen ◽  
Punam Malik ◽  
Gregory M. Vercellotti

1982 ◽  
Vol 52 (3) ◽  
pp. 455-463 ◽  
Author(s):  
Karlene P. Mason ◽  
Yvonne Grandison ◽  
R. J. Hayes ◽  
Beryl E. Serjeant ◽  
G.R. Serjeant ◽  
...  

1989 ◽  
Vol 72 (3) ◽  
pp. 434-438 ◽  
Author(s):  
David T. Dunn ◽  
Damayanti Poddar ◽  
Beryl E. Serjeant ◽  
Graham R. Serjeant

2013 ◽  
Vol 65 ◽  
pp. 1101-1109 ◽  
Author(s):  
Danilo Grunig Humberto Silva ◽  
Edis Belini Junior ◽  
Eduardo Alves de Almeida ◽  
Claudia Regina Bonini-Domingos

1992 ◽  
Vol 67 (4) ◽  
pp. 517-520 ◽  
Author(s):  
K Bailey ◽  
J S Morris ◽  
P Thomas ◽  
G R Serjeant

2021 ◽  
Author(s):  
Satashree Paul ◽  

Researchers at the Fulcrum Therapeutics developed a bioavailable drug candidate called FTX 6058 – (a novel small molecular fetal haemoglobin inducer for sickle cell disease) that can restore the body’s ability to produce fetal haemoglobin


2018 ◽  
Vol 183 (5) ◽  
pp. 807-811 ◽  
Author(s):  
Umar K. Mian ◽  
Joyce Tang ◽  
Ana P. M. Allende ◽  
Moonseong Heo ◽  
Nicole Bernstein ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document